Cargando…
Association of hydroxychloroquine and cardiac arrhythmia in patients with systemic lupus erythematosus: A population-based case control study
OBJECTIVES: Hydroxychloroquine is widely used to treat certain viral and rheumatic diseases including systemic lupus erythematosus. Cardiac arrhythmia is an important safety issue with hydroxychloroquine. The aim of this study was to investigate whether hydroxychloroquine increases new-onset arrhyth...
Autores principales: | Lo, Chien-Hsien, Wang, Yu-Hsun, Tsai, Chin-Feng, Chan, Kuei-Chuan, Li, Li-Ching, Lo, Tse-Hsien, Wei, James Cheng-Chung, Su, Chun-Hung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136629/ https://www.ncbi.nlm.nih.gov/pubmed/34015030 http://dx.doi.org/10.1371/journal.pone.0251918 |
Ejemplares similares
-
Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study
por: Lo, Chien-Hsien, et al.
Publicado: (2021) -
Hydroxychloroquine ototoxicity in a patient with systemic lupus
erythematosus
por: Fernandes, Mariana Rita de Novaes, et al.
Publicado: (2018) -
Long-Term Hydroxychloroquine Therapy and Risk of Coronary Artery Disease in Patients with Systemic Lupus Erythematosus
por: Yang, Deng-Ho, et al.
Publicado: (2019) -
Hydroxychloroquine-induced retinal toxicity in systemic lupus erythematosus
por: Piggott, Kisha D, et al.
Publicado: (2018) -
Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge
por: Dima, Alina, et al.
Publicado: (2022)